2019-12-16 11:37:00 Mon ET
technology antitrust competition bilateral trade free trade fair trade trade agreement trade surplus trade deficit multilateralism neoliberalism world trade organization regulation public utility current account compliance
America and China cannot decouple decades of long-term collaboration in trade, finance, and technology. In recent times, some economists claim that China may attempt to decouple decades of trade collaboration with the U.S. due to better tech supremacy on the eastern front. Several other economists further claim that China may try to revamp financial services and technological innovations well ahead of America.
Goldman Sachs chief strategy officer Stephanie Cohen indicates that these claims are overdone. In fact, Goldman continues to pursue fresh business opportunities in China after at least 2 decades of investment bank penetration there. In recent years, Goldman Sachs invests $60 million to bail out many depositors in Chinese brokerage firm Hainan Securities, which offers rich political connections in the one-party regime. Moreover, Goldman Sachs receives official approval from the China Securities Regulatory Commission (CSRC) to boost its equity stakes in Goldman Sachs Gao Hua Securities to the maximum cap of 51% from 33%. With managerial control over the joint venture, Goldman Sachs retains a key competitive advantage over its rivals such as JPMorgan Chase, UBS, and Nomura etc. This competitive edge empowers Goldman Sachs to further invest in Sino-American trade, finance, and technology in light of the new bilateral fair trade agreement.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2019-08-08 09:35:00 Thursday ET

Kobe Bryant and several other star athletes have been smart savvy investors. In collaboration with former Web.com CEO Jeff Stibel, the NBA champion invests
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2018-07-11 09:39:00 Wednesday ET

In recent times, the Trump administration sees the sweet state of U.S. economic expansion as of early-July 2018. The latest CNBC All-America Economic Survey
2018-03-25 08:39:00 Sunday ET

President Trump imposes punitive tariffs on $60 billion Chinese imports in a brand-new trade war as China hits back with retaliatory tariffs on $3 billion U
2025-10-12 13:32:00 Sunday ET

Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fund
2019-01-23 11:32:00 Wednesday ET

Higher public debt levels, global interest rate hikes, and subpar Chinese economic growth rates are the major risks to the world economy from 2019 to 2020.